Roche & Sanofi
9 shared events · Importance 3 · Last updated Jul 29, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Roche: Roche is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Sanofi: Sanofi is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Regulatory
Roche: One of the nine companies whose chairs signed the letter seeking faster trials, IP protections and fiscal flexibility in Europe. The move highlights its stake in European research and development competitiveness.
Sanofi: A signatory of the open letter calling on the European Union to boost pharmaceutical investment. The appeal reflects its concern about Europe lagging the United States and China in drug research and trials.
Sep 22, 2026 · 6 articles
Tech
Roche: Roche collaborates with Nurix on bexobrutideg development and co-commercialization in the US; the trial strengthens its oncology pipeline.
Sanofi: Sanofi collaborates with Nurix on a STAT6 degrader, but this event does not directly affect that program.
Aug 04, 2026 · 6 articles
Business
Roche: Roche gains co-development and co-commercialization rights to bexobrutideg, a potential best-in-class BTK degrader, expanding its pipeline in oncology, immunology, and neurology.
Sanofi: Sanofi has a separate collaboration with Nurix for a STAT6 degrader, but is not directly involved in this event.
Jul 21, 2026 · 6 articles
Business
Roche: Roche is a partner of Orano in developing targeted alpha therapies, suggesting potential for future collaboration and expansion in the oncology market.
Sanofi: Sanofi is a partner of Orano in developing targeted alpha therapies, indicating potential future collaboration and market opportunities in cancer treatment.
Jul 01, 2026 · 9 articles
Business
Roche: Roche is a collaboration partner of Nurix, co-developing bexobrutideg. The conference participation may highlight this collaboration, but no material impact on Roche is expected.
Sanofi: Sanofi is a collaboration partner of Nurix, working on STAT6 degraders. The conference participation may highlight this collaboration, but no material impact on Sanofi is expected.
Sep 01, 2026 · 6 articles
Tech
Roche: Segev received honoraria; unrelated.
Sanofi: Segev received honoraria; unrelated to study.
Sep 04, 2026 · 7 articles
Tech
Sanofi: Sanofi is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Apr 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Roche and Sanofi interact across events, view sentiment trends, and discover connected entities.
Open Dashboard